Cooper and Inspira Cardiac Care First in the Region to Implant New Heart Valve Replacement for Triscuspid Regurgitation
(CAMDEN, NJ) – A team of cardiologists at Cooper and Inspira Cardiac Care recently became the first in the region to implant the EVOQUE tricuspid valve replacement system, the first transcatheter therapy to receive U.S. Food and Drug Administration (FDA) approval for the treatment of tricuspid regurgitation. The procedure took place at Cooper University Hospital in Camden.
Tricuspid regurgitation, also known as tricuspid valve regurgitation, is a heart valve disease that occurs when the tricuspid valve doesn’t close properly. Read more.



In a commitment to furthering its partnership with Cooper University Health Care and bolstering essential services for the Camden community, Subaru of America, Inc., has announced its continued support of $30,000 for durable medical equipment and transportation services to continue to fuel Cooper’s mission. This donation, part of the Subaru Loves to Care® initiative, aims to provide access to vital medical equipment to Camden City residents.
Cooper University Health Care has been named on